Simon-Alexandre Lovasco
Family Medicine · Taylor Mill, KYNPI 1083978019
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 287 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,659 and has fallen 99.0% since, to $16 in 2024.
Across 287 payments — averaging $14.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$681
- AstraZeneca$463
- Pfizer$320
- Novo Nordisk$315
- Johnson & Johnson$234
- Lilly USA, LLC$211
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,048100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 47 | $681 |
| AstraZeneca | 18 | $463 |
| Pfizer | 33 | $320 |
| Novo Nordisk | 22 | $315 |
| Johnson & Johnson | 19 | $234 |
| Lilly USA, LLC | 20 | $211 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $210 |
| Merck | 25 | $208 |
| Boehringer Ingelheim | 11 | $167 |
| GSK | 11 | $162 |
| Abbott | 9 | $158 |
| Amgen(2 entities) | 10 | $157 |
| Sanofi-aventis U.S. LLC | 8 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $78 |
| Novartis | 4 | $68 |
| Bayer | 4 | $67 |
| Teva Pharmaceuticals USA, Inc. | 5 | $65 |
| Amarin Pharma, Inc. | 3 | $65 |
| Dexcom, Inc. | 1 | $47 |
| Biohaven Pharmaceuticals, Inc. | 3 | $41 |
| Astellas Pharma US Inc | 2 | $33 |
| Almatica Pharma LLC | 1 | $29 |
| Gilead | 2 | $28 |
| Radius Health, Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| Exact Sciences | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Bausch Health US, LLC | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$4,048 in reported general payments places this provider in the 80th percentile of 1,559 family medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 48 | $274 |
| Omeprazole | 18 | $214 |
| Pantoprazole Sodium | 19 | $201 |
| Rosuvastatin Calcium | 11 | $102 |
| Lisinopril | 17 | $87 |
| Amlodipine Besylate | 16 | $74 |
| Furosemide | 15 | $43 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Taylor Mill
- Christopher RhyneLouisville$933K
- John RichardLexington$226K
- James TurnboPaducah$124K
- Edward SchumannFlorence$79K
- Ronald KoffNew Castle$71K
- Suraj GathaniLouisville$69K
- Bradley GrayFlorence$51K
- Jackie KazeeAshland$45K
- Mandy WhittLouisville$38K
- Derek JonesAshland$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.